Our Governance
Governance as the strong foundation of SANBS’ business
Our Governance
Reporting frameworks, process and combined assurance
Research and development activities
The team authored/co-authored 19 scientific papers/publications/book chapters.
Expansion of the SANBS Mobile Stem Cell Transplant unit and their application for JACIE accreditation.
Noted the updates regarding grants, in light of the changing political priorities in the USA, the funding of SANBS’ re-application for the National Institute of Health G11 grant had been placed on hold.
Noted progress on the operationalisation of the Faecal Microbiota Bank with optimisation of procedures and training of collections staff completed.
Research projects and updates
Noted the launch of two key long-term studies: the Hepatitis C Serology Testing Study, an international trial examining if serological testing for Hepatitis C can be safely discontinued where more sensitive molecular testing is in place while balancing safety and cost-effectiveness, and the Malaria Testing Study, which explores the possibility of reinstating previously deferred donors through highly sensitive malaria testing to recover valuable donors.
The testing for the longitudinal SARS CoV-2 Seroprevalence Study was completed.
A study assessing the relationship between ferritin and hemoglobin relative to HIV status has been completed.
Various major research collaborations, including one with the blood genomics consortium which aims to develop affordable, accurate and comprehensive molecular blood group, HLA, and HPA testing.
Workforce planning
Considered the training of medical professionals, highlighting key points:
- ANBS competes with both public and private sectors for a limited number of eligible nurses
- A shortage of HPCSA-accredited laboratories restricted student placements and exam eligibility, though HPCSA has extended registrations for 10 trainee laboratory assistants
Future focus areas 2026
The key focus areas for the CGC for the year ahead will include:
- A shift in focus from meeting the demand for key blood components to ensuring a sustainable donor base to meet future blood requirements, while enabling greater flexibility in donor return patterns to minimise the risk of iron deficiency
- Adequate data and information life-cycle management and governance, including the resourcing to support these initiatives
- Maintaining adequate and appropriate stakeholder engagement and public confidence
- Ensuring appropriate quality standards and systems, assured through relevant accreditations and regulatory compliance audits
- Approving the implementation of the revised Quality Scorecard used to provide management and the CGC with an overview of the effectiveness of the SANBS Quality Management Systems
- Continued oversight of the blood bank project to improve process efficiency, accuracy, digitalisation of processes and appropriately staffed blood banks
- Ongoing monitoring of developments around NHI as these occur
Top risks
Capitals
King IV™™
Stakeholders
